SCHEMBL28243997

SCHEMBL28243997

CCCc1c(C(N)=O)cccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 4/20 0.44
CYP3A4 P08684 2/20 0.44
KCNH2 Q12809 1/20 0.44
PARP1 P09874 3/20 0.41
F2R P25116 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39
AURKB Q96GD4 1/20 0.39
CTSS P25774 4/20 0.39
CTSK P43235 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
P2RX7 Q99572 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.38
MAPK8 P45983 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29286662 0.87 CD38 (0.46) CD38CYP3A4KCNH2PARP1F2R
Hydrochloric Acid SCHEMBL4589099 0.86 CD38 (0.45) CD38CYP3A4KCNH2PARP1F2R
SCHEMBL2964481 0.83 PARP1 (0.45) CYP3A4PARP1KDM4EALDH1A1HPGD
SCHEMBL28204448 0.80 PARP1 (0.50) CD38CYP3A4KCNH2PARP1SIRT2
SCHEMBL10061561 0.79 ALDH1A1 (0.41) F2RCTSSCTSKKDM4EALDH1A1
SCHEMBL21439307 0.79 MAPK8 (0.44) CD38CYP3A4KCNH2PARP1KDM4E
SCHEMBL6422087 0.78 CD38 (0.41) CD38CYP3A4KCNH2PARP1SIRT2
SCHEMBL27486467 0.77 TAS2R14 (0.49) F2RCTSSKDM4EALDH1A1P2RX7
SCHEMBL5685703 0.77 ALDH1A1 (0.42) CYP3A4PARP1KDM4EALDH1A1HPGD
SCHEMBL3352032 0.77 PARP1 (0.41) CYP3A4PARP1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108467369-A BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS 诺华股份有限公司 2018-08-31 CN disclosed